vimarsana.com

எழுந்திரு காடு ஞானஸ்நானம் விரிவான புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study shows safety and efficacy of radio-wave therapy for liver cancer patients

Study shows safety and efficacy of radio-wave therapy for liver cancer patients Researchers at Wake Forest School of Medicine have shown that a targeted therapy using non-thermal radio waves is safe to use in the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer. The therapy also showed a benefit in overall survival. The study findings appear online in 4Open, a journal published by EDP Sciences. HCC accounts for nearly 90% of all liver cancers, and current survival rates are between six and 20 months. Currently, there are limited treatment options for patients with this advanced liver cancer. Boris Pasche, M.D., Ph.D., chair of cancer biology and director of Wake Forest Baptist s Comprehensive Cancer Center

Young people have fallen behind on vaccinations during the pandemic, experts say Can the COVID-19 vaccine help change that?

The pending availability of a second COVID-19 vaccine for 12- to 17-year-olds has local infectious diseases experts hopeful it will spur young people to catch up on all vaccinations. Moderna said Tuesday that the first dose of its vaccine was 93% effective in that age range following a study on more than 3,700 young people. The drug maker said it saw no COVID-19 diagnoses in study participants who got two doses. The company plans to submit its data in early June to the Food and Drug Administration for the same emergency-use authorization given to the Pfizer vaccine. Our vaccination sites continue to see higher volumes of younger individuals ages 12 to 15 since the Pfizer vaccine was authorized for emergency use, Dr. David Priest, an infectious diseases expert with Novant Health said Tuesday.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.